Sarvada Pharma

Twinaqt (50mg Dolutegravir/300mg Lamivudine) is a prescription combination medication used to treat HIV-1 infection in adults and adolescents (over 12 years old, weighing at least 40 kg). It works by reducing the amount of HIV in the body, which helps strengthen the immune system and reduces the risk of AIDS-related illnesses. 

Inbec tablet (600/50/300mg) is a combination of Abacavir, Dolutegravir, and Lamivudine used to treat HIV infection in adults and adolescents (weighing at least 40 kg). It works by decreasing the amount of virus in the body, improving immune function, and reducing HIV-related complications. 

Myltega 50mg tablets, containing dolutegravir, are an antiretroviral medication used in combination with other medicines to treat HIV-1 infection in adults and children (at least 6 years old or over 40kg). It inhibits the integrase enzyme, reducing the viral load, increasing CD4 cells, and strengthening the immune system. 

50 mg Tivicay (dolutegravir) tablets are used in combination with other antiretroviral medications to treat HIV-1 infection in adults and children (at least 4 weeks old and weighing  3 kg). As an integrase strand transfer inhibitor (INSTI), it prevents the virus from multiplying, reduces the viral load, and helps increase immune cell counts. 

Acriptega is a prescription combination medication containing Dolutegravir, Lamivudine, and Tenofovir disoproxil fumarate, designed to treat HIV-1 infection in adults and adolescents. It works by inhibiting key enzymes needed for HIV replication, thus reducing viral load and boosting immunity. 

Ralmac Raltegravir 400mg tablet is an antiretroviral medication used to manage HIV-1 infection in adults and children (weighing at least 2 kg). It works by inhibiting the virus's ability to replicate, which lowers the amount of HIV in the body, aids immune system function, and helps prevent AIDS-related illnesses.